• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of FDA advisory committee member positions vacant at the end of the month

Dictionary: Access to state-of-the-art, scientific expert advice to support agency decision making processes is imperative to the FDA advisory committee process. Having the fewest vacancies on our committees allows the agency to have ready access to those experts and supports the ability of FDA to meet its public health mission. For more information about FDA advisory committees, please visit http://www.fda.gov/AdvisoryCommittees/default.htm

Information is current as of March 31, 2014.

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetPercent Vacant Positions
Oct 20121020
Nov 20121020
Dec 20121020
Jan 20131020
Feb 20131021
Mar 20131022
Apr 20131021
May 20131022
Jun 20131023
Jul 20131022
Aug 20131016
Sep 20131014

Number of FDA advisory committee member positions vacant at the end of the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetVacant Positions
Oct 2012N/A126
Nov 2012N/A124
Dec 2012N/A129
Jan 2013N/A129
Feb 2013N/A130
Mar 2013N/A137
Apr 2013N/A136
May 2013N/A139
Jun 2013N/A146
Jul 2013N/A137
Aug 2013N/A99
Sep 2013N/A89

Total number of FDA advisory committee member positions at the end of the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetPositions
Oct 2012N/A634
Nov 2012N/A634
Dec 2012N/A634
Jan 2013N/A634
Feb 2013N/A634
Mar 2013N/A634
Apr 2013N/A634
May 2013N/A634
Jun 2013N/A634
Jul 2013N/A634
Aug 2013N/A634
Sep 2013N/A620

Footnotes

  • CVM's Advisory Committee was terminated on September 30, 2013.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.